Revive Therapeutics Enters LOI To Acquire Psilocybin Program From PharmaTher
Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a letter of intent to acquire PharmaTher Inc’s
Read more
Psilocybin
Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics
For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh
Read more
Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product
Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after several months of prototyping. The
Read more
Parallels of Psychedelic Mushrooms and Cannabis
Psychedelics are a class of pharmacological compounds that produce unique and profound changes of consciousness. The most common psychedelics are
Read more
Shroom Boom! Has Michael Frank Brought Revive Back from the Dead?
Yesterday Revive Therapeutics (CSE: RVV) increased 81.8% from 5.5c to 10c on 4.1M shares traded. Presumably, RVV is beginning to
Read more
Yield Growth Corp Continues Push Towards Psychedelic Mushroom Investment Narrative
The Yield Growth Corp (CSE: BOSS) is continuing to push its recently announced psilocybin mushroom narrative. The firm announced today
Read more
Yield Growth Corp To Enter Mushroom and Psychoactive Space
The Yield Growth Corp (CSE: BOSS) is newly focused on the mushroom business – both in terms of edibles as
Read more
Roadman Investments To Establish Psychedelic Conference for Investors
Roadman Investments (TSXV: LITT), a firm focused on the production of mushrooms, announced this morning that it has formed a
Read more